Stable liquid pharmaceutical formulation of IGG antibodies
Details for Australian Patent Application No. 2002363339 (hide)
International Classifications
Event Publications
19 June 2003 Complete Application Filed
Priority application(s): 60/337,509 08.11.01 US
24 July 2003 Application Open to Public Inspection
Published as AU-B-2002363339
26 October 2006 Change of Name(s) of Applicant(s), Section 104
Protein Design Labs The name of the applicant has been changed to PDL BioPharma, Inc. 2003
7 February 2008 Application Accepted
Published as AU-B-2002363339
5 June 2008 Standard Patent Sealed
22 October 2009 Assignment Registered
PDL BioPharma, Inc. The patent has been assigned to Facet Biotech Corporation
3 February 2011 Alteration of Name
The name of the patentee has been altered to Abbott Biotherapeutics Corp. 2003 Amendments
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002363338-DIAGNOSTICS AND THERAPEUTICS FOR OCULAR ABNORMALITIES
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser